Technology Review - Published By MIT
Advertisement
TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.
I'm a paid subscriber please
log me in
I want to purchase this article for
only 99¢
(requires login)
I want to purchase five articles for
only $3.99
(requires login)
I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

Click here if you are an MIT alum and do not have access to this article.

Wednesday, November 01, 2006

On Autism's Trail

Affymetrix's microarrays will provide insight into complex genetic diseases.

By Emily Singer

A new gene chip from Santa Clara, CA based Affymetrix. (Courtesy of Affymetrix).

A new microarray that can simultaneously detect 500,000 or more specific genetic variations, covering almost every gene in the genome, will provide better insights into the complex genetic bases of many illnesses. Using the chip from Santa Clara, CA-based Affymetrix (a similar one is made by San Diego-based Illumina), researchers worldwide are seeking genetic causes of diseases such as autism, diabetes, and ­Alzheimer's. Below is a sampling of these efforts. Emily Singer

  Select from the choices above
to read the entire article.


Log In

Forgot your password?     Register »
Advertisement

Videos

Making 3D Maps on the Move
Technology Review November/December 2009

Current Issue

Natural Gas Changes the Energy Map
The United States has vast supplies of this cleaner fossil fuel. But how should we use it?
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.